Because EGF was shown to induce AR transcription by upregulating TIF2 expression in prostate cancer cells (21), we then determined the levels of TIF2 expression in bladder cancer cell lines upon treatment with EGF, androgen and/or antiandrogen. This evidence concerns the gene NCOA2 and urinary bladder cancer.